Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study

Chih Hung Hsu, Yoon Koo Kang, Tsai Shen Yang, Chia Tung Shun, Yu Yun Shao, Wu Chou Su, Jennifer Sandoval-Tan, Tzeon Jye Chiou, Kate Jin, Chiun Hsu, Ann Lii Cheng

Research output: Contribution to journalArticlepeer-review

40 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences